Related Experiment Videos
Nitric oxide production during exercise in chronic heart failure
H Adachi1, P H Nguyen, R Belardinelli
1Division of Respiratory and Critical Care Physiology and Medicine, Harbor-UCLA Medical Center, Torrance, USA.
American Heart Journal
|August 1, 1997
Summary
Patients with chronic heart failure have lower nitric oxide (NO) production during exercise. This reduced NO may contribute to impaired vasodilation and increased ventilation in heart failure patients.
Area of Science:
- Cardiology
- Pulmonary Physiology
- Biomedical Science
Background:
- Chronic heart failure (CHF) is associated with an exaggerated ventilatory response to exercise.
- Reduced lung perfusion in CHF may contribute to this altered breathing pattern.
- Nitric oxide (NO), a vasodilator, plays a role in pulmonary circulation and its production increases with exercise in healthy individuals.
Purpose of the Study:
- To quantify exhaled nitric oxide (NO) output during exercise in patients with chronic heart failure (CHF).
- To compare NO production during exercise between CHF patients and healthy subjects.
- To investigate the potential role of NO in the abnormal ventilatory response to exercise in CHF.
Main Methods:
- Symptom-limited incremental exercise testing was performed on a cycle ergometer in six CHF patients and six healthy subjects.
- Oxygen uptake (VO2), carbon dioxide output (VCO2), and minute ventilation (VE) were measured breath-by-breath.
- Exhaled NO concentration was continuously measured using chemiluminescence.
Main Results:
- Peak exercise work rate was significantly lower in CHF patients compared to normal subjects.
- CHF patients exhibited a higher VE/VCO2 ratio at peak exercise.
- Resting exhaled NO concentration and NO output (VNO) were lower in CHF patients. During exercise, VNO increased but to a lesser extent in CHF patients compared to controls.
Conclusions:
- Patients with CHF demonstrate a blunted increase in nitric oxide (NO) production during exercise.
- This impaired NO production may contribute to reduced pulmonary vasodilation and the heightened ventilatory response observed in CHF.
- Findings suggest a potential therapeutic target for improving exercise capacity in chronic heart failure.